Chapter 57: Sexually Transmitted Infection Drug Therapy
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Sexually Transmitted Infection Drug Therapy details the various transmission routes, including direct sexual contact, exposure to contaminated blood, and vertical transmission from parent to child during pregnancy, birth, or breastfeeding. The text categorizes major pathogens into bacterial, viral, and parasitic groups, emphasizing the risks associated with asymptomatic cases. Key bacterial infections like Chlamydia and Gonorrhea are discussed for their potential to cause severe reproductive damage such as pelvic inflammatory disease and infertility. The complex, multi-stage progression of Syphilis—from initial painless sores to potentially fatal systemic and neurological involvement—is outlined alongside specific diagnostic antibody testing and penicillin-based treatment protocols. For incurable viral infections like Herpes Simplex Virus, Human Immunodeficiency Virus, and Human Papillomavirus, the focus shifts to palliative antiviral therapies and preventative vaccinations to mitigate long-term health risks and oncogenic potential. The discussion extends to other common conditions like Trichomoniasis, bacterial vaginosis, and parasitic infestations like Scabies, emphasizing the importance of specific drug regimens and the necessity of avoiding alcohol during certain antibiotic treatments to prevent dangerous disulfiram-like reactions. A significant portion of the material is dedicated to the nursing process, prioritizing patient safety, thorough assessment, and education on consistent barrier method use. Special attention is given to the rising infection rates among older adults and the essential prophylactic measures taken to protect neonates, such as the routine administration of antibiotic eye ointment. By integrating pharmacological knowledge with patient-centered care and partner notification strategies, healthcare providers can better manage the physical and psychosocial impacts of these pervasive infections while working toward community-wide prevention.